Tenpoint Therapeutics Launches YUVEZZITM Direct-to-Consumer Campaign Featuring a Cast of Hand-Crafted Puppets Giving a Voice to the Everyday Fusses of Blurry Close-Up Vision

Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced the launch of Friends of the Presbyopians, its first national consumer campaign for YUVEZZITM (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, the first and only dual-agent, once-daily prescription eye drop approved by the U.S. Food and Drug Administration (FDA) for the treatment of presbyopia.